For comments, suggestions
Created with Raphaël 2.1.0 31.08.2018 Filing date 13.09.2021 Validation fee payment 30.04.2022 (A1) Patent application published 17.09.2024 AGEPI application filing date 30.11.2024 (T2) Translation of the validated European patent 03.05.2025 31.08.2025 Valid until 01.09.2026 Renewal fee to be paid until 31.08.2038 Patent will expire on

Patent in force


(210)Number of the EPO application21196378
(220)Filing date of the EPO application2018.08.31
(80)EPO patent specification publication (B)EPB nr. 31/2024, 2024.07.31
(110)EPO patent number3973982
(11)Number of the documentMD 3973982 T2
(21)Number of the applicatione 2022 0351
(71)Name(s) of applicant(s), code of the countryFERRING B.V., NL;
(72)Name(s) of inventor(s), code of the countryARCE SAEZ Joan-Carles, DK;
HELMGAARD Lisbeth, DK;
KLEIN Bjarke Mirner, DK;
(73)Name(s) of owner(s), code of the countryFERRING B.V., NL;
(54)Title of the inventionComposition for controlled ovarian stimulation
(13)Kind-of-document code T2
(51)International Patent Classification A61K 38/24 (2006.01.01); A61P 15/08 (2006.01.01)
(19)CountryNL
(41)Date of publication of the application2022.04.30
(49)Date of publication of the translation of the validated European patent specification2024.11.30
(30)Priority17189119, 2017.09.01, EP
(74)Patent attorney(Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova
Up
/Inventions/details/3973982